Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ATXN10 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA568098
Description
Predicted to react with Mouse and Rat samples.
The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders characterized by ataxia, dysarthria, dysmetria, and intention tremor. All ADCAs involve some degree of cerebellar dysfunction and a varying degree of signs from other components of the nervous system. A commonly accepted clinical classification (Harding, 1993) divides ADCAs into 3 different groups based on the presence or absence of associated symptoms such as brainstem signs or retinopathy. The presence of pyramidal and extrapyramidal symptoms and ophthalmoplegia makes the diagnosis of ADCA I, the presence of retinopathy points to ADCA II, and the absence of associated signs to ADCA III. Genetic linkage and molecular analyses revealed that ADCAs are genetically heterogeneous even within the various subtypes.
Specifications
ATXN10 | |
Polyclonal | |
Unconjugated | |
ATXN10 | |
AI325283; ataxin 10; ataxin 10 homolog; ataxin-10; ATXN10; Brain protein E46; brain protein E46 homolog; C77170; E46; E46L; HUMEEP; Neuronal beta-catenin-like protein; Sca10; spinocerebellar ataxia 10; spinocerebellar ataxia 10 homolog; spinocerebellar ataxia type 10 protein; Spinocerebellar ataxia type 10 protein homolog; TEG-169; testis expressed gene 169; Tex169 | |
Rabbit | |
Affinity chromatography | |
RUO | |
170821, 25814, 54138 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 30% glycerol and 0.02% sodium azide; pH 7.3 | |
P28658, Q9ER24, Q9UBB4 | |
ATXN10 | |
Synthesized peptide derived from human ATXN10. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction